Share

Novavax says its Covid vaccine is 90% effective in late stage trial

Biotech firm Novavax said its Covid-19 vaccine was shown to be safe and 90.4% effective overall in a phase three clinical trial. CNBC's Becky Quick and Meg Tirrell discuss.
01:27
Mon, Jun 14 20219:25 AM EDT